1st Quarter - Report

ONCOLOGY NURSING SOCIETY for ONCOLOGY NURSING SOCIETY

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Monitoring healthcare regulations and legislation; Palliative Care Hospice Education & Treatment Act PCHETA (H.R 647); Cancer Drug Parity Act (H.R. 1730/S. 741);Title VIII Nursing Reauthorization Act (HR 728); Lymphedema Treatment Act (H.R. 1948/S. 518); Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act"; Clinical Treatment Act (H.R. 913)

LobbyistCovered position, as disclosed
ALEC STONE Clinton White House, Women's Health Initiatives
DONNA SLINGLUFF SWEENEY New —

Contacted: Natl Institutes of Health (NIH); SENATE; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 647 (116th), S. 518 (116th), H.R. 913 (116th), H.R. 1948 (116th), H.R. 1730 (116th), S. 741 (116th), H.R. 728 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.